Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Homology Medicines Inc
(NQ:
FIXX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Homology Medicines Inc
< Previous
1
2
3
4
5
Next >
Bronstein, Gewirtz & Grossman, LLC Notifies Homology Medicines, Inc. (FIXX) Shareholders of Class Action and Encourages Investors to Contact the Firm
March 31, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Investor Action Reminder: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
March 30, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
FIXX Shareholder Class Action: Robbins LLP Reminds Investors of Class Action Against Homology Medicines, Inc. (FIXX)
March 29, 2022
From
Robbins LLP
Via
Business Wire
EQUITY NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FIXX
March 29, 2022
From
Rosen Law Firm
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
March 29, 2022
From
The Schall Law Firm
Via
Business Wire
ALERT: Homology Medicines, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FIXX
March 28, 2022
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
SHAREHOLDER ALERT: Robbins LLP Informs Shareholders of Class Action Against Homology Medicines, Inc. (FIXX)
March 28, 2022
From
Robbins LLP
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
March 28, 2022
From
The Schall Law Firm
Via
Business Wire
Homology Medicines's Return On Capital Employed Overview
March 24, 2022
Benzinga Pro data, Homology Medicines (NASDAQ:FIXX) reported Q4 sales of $802.00 thousand. Earnings fell to a loss of $33.58 million, resulting in a 9.72% decrease from last...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 16, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 14, 2022
Gainers Erytech Pharma (NASDAQ:ERYP) stock rose 18.7% to $1.65 during Monday's pre-market session. The market value of their outstanding shares is at $51.1 million....
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 28, 2022
Gainers IntriCon (NASDAQ:IIN) shares increased by 37.4% to $23.93 during Monday's regular session. The current volume of 1.0 million shares is 3684.0% of IntriCon'...
Via
Benzinga
Analyst Ratings For Homology Medicines
February 28, 2022
Analysts have provided the following ratings for Homology Medicines (NASDAQ:FIXX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish...
Via
Benzinga
67 Biggest Movers From Yesterday
March 01, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) climbed 145.6% to close at $1.69 on Monday after the company reported progress on solid-state polymer battery pack...
Via
Benzinga
42 Stocks Moving In Monday's Mid-Day Session
February 28, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development. Renewable Energy Group...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 28, 2022
Gainers Soleno Therapeutics (NASDAQ:SLNO) shares rose 15.7% to $0.37 during Monday's pre-market session. The market value of their outstanding shares is at $29.5...
Via
Benzinga
10 Biggest Price Target Changes For Monday
February 28, 2022
Barclays cut the price target on MasTec, Inc. (NYSE: MTZ) from $140 to $120. MasTec shares fell 0.1% to $79.00 in pre-market trading.
Via
Benzinga
Mid-Afternoon Market Update: US Stocks Pare Losses; Meritor Shares Spike Higher
February 22, 2022
U.S. stocks pared back some losses toward the end of trading on Tuesday. Russian President Vladimir Putin said he would recognize the independence of two Russian-led...
Via
Benzinga
Analyst Ratings For Homology Medicines
February 22, 2022
Over the past 3 months, 4 analysts have published their opinion on Homology Medicines (NASDAQ:FIXX) stock. These analysts are typically employed by large Wall Street banks and...
Via
Benzinga
73 Biggest Movers From Yesterday
February 23, 2022
Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 22, 2022
Gainers Ocugen (NASDAQ:OCGN) stock rose 25.0% to $4.33 during Tuesday's regular session. As of 12:30 EST, Ocugen's stock is trading at a volume of 42.0 million,...
Via
Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
February 22, 2022
Gainers Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87. Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday...
Via
Benzinga
Mid-Day Market Update: Stocks Extend Losses; Dow Tumbles Over 400 Points
February 22, 2022
U.S. stocks extended its earlier losses midway through trading on Tuesday, amid rising tensions between Russia and Ukraine. Russian President Vladimir Putin said he would...
Via
Benzinga
Mid-Morning Market Update: U.S. Markets Mixed Amid Russia-Ukraine Woes
February 22, 2022
U.S. stocks traded mixed this morning, amid rising tensions between Russia and Ukraine. Russian President Vladimir Putin said he would recognize the independence of two Russian-...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 22, 2022
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 15.5% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $213.3 million....
Via
Benzinga
Homology Medicines Stock Plunges After FDA Clinical Hold On Gene Therapy Trial
February 22, 2022
The FDA has placed a clinical hold on Homology Medicines Inc's (NASDAQ: FIXX) pheNIX gene therapy trial of HMI-102 from the FDA. An official clinical hold...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 22, 2022
With the long weekend over it's time to start another week of trading with the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
10 Biggest Price Target Changes For Tuesday
February 22, 2022
Wells Fargo lowered DraftKings Inc. (NASDAQ: DKNG) price target from $41 to $19. DraftKings shares dropped 5.8% to $16.28 in pre-market trading.
Via
Benzinga
Supernus (SUPN) Moves 5.7% Higher: Will This Strength Last?
February 21, 2022
Supernus Pharmaceuticals shares soared 5.7% in the last trading session to close at $32.90. The move was backed by solid volume with far more shares changing hands than in a normal session.
Via
Talk Markets
Oxford Biomedica, Homology Medicines Enter Deal To Expand Viral Vector Offerings
January 28, 2022
London-listed cell and gene therapy Oxford Biomedica Plc (OTC: OXBDF) said it would form a viral vector manufacturing business with Homology Medicines Inc (NASDAQ: FIXX).
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.